Kaupinen Wes

Palvella Therapeutics, Inc. · President and CEO

Kaupinen Wes is listed in public filings as director, 10 percent owner, officer: President and CEO. This Kaupinen Wes insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Palvella Therapeutics, Inc. (PVLA). Investors use Kaupinen Wes's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Palvella Therapeutics, Inc.PVLA$9.5M124.6k sharesGrant / ExerciseFeb 5, 2026$9.5M124.6k shares$76.43--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Palvella Therapeutics, Inc.PVLA$3.6M243.8k sharesGrant / ExerciseFeb 5, 2025$3.6M243.8k shares$14.76--
Palvella Therapeutics, Inc.PVLA$5.7M417.8k sharesGrant / ExerciseDec 13, 2024$5.7M417.8k shares$13.60--